{"nct_id":"NCT02535078","title":"Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma","status":"WITHDRAWN","status_verified_date":"2024-07","start_date":"2015-11","start_date_type":"ACTUAL","primary_completion_date":"2023-06-19","primary_completion_date_type":"ACTUAL","completion_date":"2023-09-06","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["IMCR"]}